CLINICAL_TRIALS
trial_result
· 2018-04-23
Clinical Trial Update: The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse [Phase 2]
Summary
Phase 2 study evaluating whether naltrexone and varenicline together reduce alcohol-triggered smoking lapses in smokers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Smoking | Phase 2 | Status: COMPLETED | Results posted: 2018-04-23